Drugs / Symbicort Turbohaler
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 met primary | ||||||
| Phase 1 | NCT02189304 | Jun → Sep 2014 | chronic obstructive pulmonary disease | Pearl Therapeutics, Inc. | Completed | Met primary |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT02227394 | Aug → Nov 2014 | chronic asthma | Zambon SpA | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01099722 Comparator | Apr → Nov 2010 | asthma | Mundipharma Research Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Symbicort Turbohaler | “Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid)” NCT01099722 ↗ |
| Route | Inhaled | “Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid)” NCT01099722 ↗ |